Cited by 828PI3K/AKT/mTOR signaling in cancerTuberous Sclerosis Complex ResearchMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling

Open access

Tee, Andrew R., Fingar, Diane C., Manning, Brendan D., Kwiatkowski, David J., Cantley, Lewis C., Blenis, John·2002·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.202476899PMC PMC129715

Open this paper in CoChat — free account

Abstract

Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder that occurs upon mutation of either the TSC1 or TSC2 genes, which encode the protein products hamartin and tuberin, respectively. Here, we show that hamartin and tuberin function together to inhibit mammalian target of rapamycin (mTOR)-mediated signaling to eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) and ribosomal protein S6 kinase 1 (S6K1). First, coexpression of hamartin and tuberin repressed phosphorylation of 4E-BP1, resulting in increased association of 4E-BP1 with eIF4E; importantly, a mutant of TSC2 derived from TSC patients was defective in repressing phosphorylation of 4E-BP1. Second, the activity of S6K1 was repressed by coexpression of hamartin and tuberin, but the activity of rapamycin-resistant mutants of S6K1 were not affected, implicating mTOR in the TSC-mediated inhibitory effect on S6K1. Third, hamartin and tuberin blocked the ability of amino acids to activate S6K1 within nutrient-deprived cells, a process that is dependent on mTOR. These findings strongly implicate the tuberin-hamartin tumor suppressor complex as an inhibitor of mTOR and suggest that the formation of tumors within TSC patients may result from aberrantly high levels of mTOR-mediated signaling to downstream targets.

Integrity signals

Registry

Crossref · 10.1073/pnas.202476899

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

TOR, a Central Controller of Cell Growth
Schmelzle, T., & Hall, M. N. (2000) · Cell · doi:10.1016/s0092-8674(00)00117-3 · Cited by 1,914
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Self-citation
Regulation of translation initiation by FRAP/mTOR
Gingras, A.-C., Raught, B., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.887201 · Cited by 1,545
Amino Acid Sufficiency and mTOR Regulate p70 S6 Kinase and eIF-4E BP1 through a Common Effector Mechanism
Hara, K., Yonezawa, K., Weng, Q.-P., Kozlowski, M. T., BELHAM, C. M., & Avruch, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14484 · Cited by 1,370
Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases
Chung, J., Kuo, C. J., Crabtree, G. R., & Blenis, J. (1992) · Cell · doi:10.1016/0092-8674(92)90643-q · Cited by 1,151
Self-citation
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093
Self-citation
Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap
Lazaris-Karatzas, A., Montine, K. S., & Sonenberg, N. (1990) · Nature · doi:10.1038/345544a0 · Cited by 971
Mammalian TOR: a homeostatic ATP sensor
Dennis, P. B., Jaeschke, A., Saitoh, M., Fowler, B., Kozma, S. C., & Thomas, G. (2001) · Science · doi:10.1126/science.1063518 · Cited by 962
A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells
Kwiatkowski, D. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.525 · Cited by 674
Self-citation
The mRNA 5′ cap-binding protein eIF4E and control of cell growth
Sonenberg, N., & Gingras, A. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80150-6 · Cited by 673

Show all 31 references

Research works printed but not linked: 4

E R Gomez, J R Sampson, V H Whittemore Developmental Perspectives in Psychiatry (Oxford Univ. Press, Oxford, 1999).
T L Plank, R S Yeung, E P Henske Cancer Res 58, 4766–4770 (1998).
Martin K. A. & Blenis J. (2002) Adv. Cancer Res. 86 in press.
D Rousseau, A C Gingras, A Pause, N Sonenberg Oncogene 13, 2415–2420 (1996).

Sorted by citations

Items 501–600 of 828

Evidence that TSC2 acts as a transcription factor and binds to and represses the promoter of Epiregulin
Pradhan, S. A., Rather, M. I., Tiwari, A., Bhat, V. K., & Kumar, A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku278 · Cited by 22
From tuberous sclerosis complex to end stage renal disease: who are these patients?
Vabret, E., Couchoud, C., Lassalle, M., & Vigneau, C. M. (2020) · Journal of Nephrology · doi:10.1007/s40620-020-00714-3 · Cited by 21
Left‐right asymmetry in the light of TOR: An update on what we know so far
Tena, T. C., Burkhalter, M. D., & Philipp, M. (2015) · Biology of the Cell · doi:10.1111/boc.201400094 · Cited by 20
Tuberous Sclerosis Complex 1: An Epithelial Tumor Suppressor Essential to Prevent Spontaneous Prostate Cancer in Aged Mice
Kladney, R. D., Cardiff, R. D., Kwiatkowski, D. J., Chiang, G. G., Weber, J. D., Arbeit, J. M., & Lu, Z. H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1646 · Cited by 21
Self-citation
mTORC1 and mTORC2 expression in inner retinal neurons and glial cells
Losiewicz, M. K., Elghazi, L., Fingar, D. C., Rajala, R. V. S., Lentz, S. I., Fort, P. E., Abcouwer, S. F., & Gardner, T. W. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108131 · Cited by 20
Self-citation
Deciphering the physiopathology of neurodevelopmental disorders using brain organoids
Dionne, O., Sabatié, S., & Laurent, B. (2024) · Brain · doi:10.1093/brain/awae281 · Cited by 22
Antiepileptic Effect and Safety Profile of Rapamycin in Pediatric Patients With Tuberous Sclerosis Complex
Sadowski, K., Sijko, K., Domańska‐Pakieła, D., Borkowska, J., Chmielewski, D., Ulatowska, A., Jóźwiak, S., & Kotulska, K. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.704978 · Cited by 20
Exonic Variants Associated with Development of Aspirin Exacerbated Respiratory Diseases
Shin, S., Park, B. L., Chang, H. S., Park, J., Bae, D.-J., Song, H., Choi, I. S., Kim, M.-K., Park, H.-S., Kim, L. H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111887 · Cited by 20
A tightly regulated IL-22 response maintains immune functions and homeostasis in systemic viral infection
Yi, P., Liang, Y., Yuan, D. M. K., Jie, Z., Kwota, Z., Chen, Y., Cong, Y., Fan, X., & Sun, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-04260-0 · Cited by 21
Increasing our understanding of human cognition through the study of fragile X syndrome
Cook, D., Nuro, E., & Murai, K. K. (2013) · Developmental Neurobiology · doi:10.1002/dneu.22096 · Cited by 22
Mechanisms of translational control in dendrites
Glanzer, J. G. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.006 · Cited by 20
Sirolimus Ointment for Facial Angiofibromas in Individuals with Tuberous Sclerosis Complex
Amin, S., Lux, A. L., Khan, M. A., & O'Callaghan, F. J. (2017) · International Scholarly Research Notices · doi:10.1155/2017/8404378 · Cited by 19
3‐Substituted Indazoles as Configurationally Locked 4EGI‐1 Mimetics and Inhibitors of the eIF4E/eIF4G Interaction
Yefidoff‐Freedman, R., Chen, T., Sahoo, R., Chen, L., Wagner, G., Halperin, J. A., Aktas, B. H., & Chorev, M. (2014) · ChemBioChem · doi:10.1002/cbic.201300723 · Cited by 19
Effects of level of nutrient intake and age on mammalian target of rapamycin, insulin, and insulin-like growth factor-1 gene network expression in skeletal muscle of young Holstein calves
Wang, P., Drackley, J. K., Lanier, J. S., Keisler, D. H., & Loor, J. J. (2013) · Journal of Dairy Science · doi:10.3168/jds.2013-7042 · Cited by 20
Mammalian target of rapamycin: A new target in prostate cancer
Rai, J. S., Henley, M., & Ratan, H. L. (2009) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.03.023 · Cited by 19
Detection of low-prevalence somatic TSC2 mutations in sporadic pulmonary lymphangioleiomyomatosis tissues by deep sequencing
Fujita, A., Ando, K., Kobayashi, E., Mitani, K., Okudera, K., Nakashima, M., Miyatake, S., Tsurusaki, Y., Saitsu, H., Seyama, K., et al. (2015) · Human Genetics · doi:10.1007/s00439-015-1611-0 · Cited by 19
Potential of Capric Acid in Neurological Disorders: An Overview
Shekhar, N., Tyagi, S., Rani, S., & Thakur, A. K. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03809-4 · Cited by 20
Anti-EGFR Antibody Reduces Lung Nodules by Inhibition of EGFR-Pathway in a Model of Lymphangioleiomyomatosis
Lesma, E. A., Chiaramonte, E., Ancona, S., Orpianesi, E., Giulio, A. M. D., & Gorio, A. (2015) · BioMed Research International · doi:10.1155/2015/315240 · Cited by 18
Factors associated with autism spectrum disorder in children with tuberous sclerosis complex: a systematic review and meta‐analysis
Mitchell, R. A., Barton, S., Harvey, A. S., Ure, A. M., & Williams, K. J. (2021) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14787 · Cited by 18
Involvement of Lymphatics in Lymphangioleiomyomatosis
Glasgow, C. G., Taveira‐DaSilva, A. M., Pacheco–Rodriguez, G., Steagall, W. K., Tsukada, K., Cai, X., El‐Chemaly, S., & Moss, J. (2009) · Lymphatic Research and Biology · doi:10.1089/lrb.2009.0017 · Cited by 18
Carbachol induces p70S6K1 activation through an ERK-dependent but Akt-independent pathway in human colonic epithelial cells
Jiang, X., Sinnett‐Smith, J. W., & Rozengurt, E. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.060 · Cited by 18
Dysregulated acetylcholine-mediated dopamine neurotransmission in the eIF4E Tg mouse model of autism spectrum disorders
Carbonell-Roig, J., Aaltonen, A., Wilson, K., Molinari, M., Cartocci, V., McGuirt, A. F., Mosharov, E. V., Kehr, J., Lieberman, O. J., Sulzer, D., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114997 · Cited by 17
The autism spectrum disorder phenotype in children with tuberous sclerosis complex: A systematic review and meta‐analysis
Mitchell, R. A., Mitchell, M. J., & Williams, K. J. (2022) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.15307 · Cited by 18
Cerebral organoids as an in vitro model to study autism spectrum disorders
Rabeling, A., & Goolam, M. (2022) · Gene Therapy · doi:10.1038/s41434-022-00356-z · Cited by 17
Analysis of TSC1 mutation spectrum in mucosal melanoma
Ma, M., Dai, J., Xu, T., Yu, S., Yu, H., Tang, H., Yan, J., Wu, X., Yu, J., Chi, Z., et al. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2550-z · Cited by 17
Sporadic renal angiomyolipoma in a patient with Birt-Hogg-Dubé: chaperones in pathogenesis
Sager, R., Woodford, M. R., Shapiro, O., Mollapour, M., & Bratslavsky, G. (2018) · Oncotarget · doi:10.18632/oncotarget.25164 · Cited by 17
mTOR-regulated U2af1 tandem exon splicing specifies transcriptome features for translational control
Chang, J.-W., Yeh, H.-S., Park, M., Erber, L. N., Sun, J., Cheng, S. L. A., Bui, A. M., Fahmi, N. A., Nasti, R. A., Kuang, R., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz761 · Cited by 18
Suppressed Expression of Autophagosomal Protein LC3 in Cortical Tubers of Tuberous Sclerosis Complex
Miyahara, H., Natsumeda, M., Shiga, A., Aoki, H., Toyoshima, Y., Zheng, Y., Takeuchi, R., Murakami, H., Masuda, H., Kameyama, S., et al. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00634.x · Cited by 17
Oral and neurocutaneous phenotypes of familial tuberous sclerosis
Araujo, L. D. J., Lima, L. S., Alvarenga, T. M. M., Martelli‐Júnior, H., Coletta, R. D., de Aquino, S. N., & Bonan, P. R. F. (2010) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2010.07.002 · Cited by 17
Inherited disorders as a risk factor and predictor of neurodevelopmental outcome in pediatric cancer
Ullrich, N. J. (2008) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.30 · Cited by 17
IGF-I activates the eIF4F system in cardiac muscle in vivo
Vary, T. C., & Lang, C. H. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-7551-6 · Cited by 17
Tuberous sclerosis-2 tumor suppressor modulates ERK and B-Raf activity in transformed renal epithelial cells
Yoon, H., Ramachandiran, S., Chacko, M. S., Monks, T. J., & Lau, S. S. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00234.2003 · Cited by 17
Correlation between epilepsy and genotype: A large retrospective tuberous sclerosis complex cohort
Ding, Y., Zhou, Y., Yu, L., Zhang, L., Zhou, S., Wang, Y., & Wang, J. (2021) · Seizure · doi:10.1016/j.seizure.2021.06.036 · Cited by 16
Parapelvic Cysts: An Imaging Marker of Kidney Disease Potentially Leading to the Diagnosis of Treatable Rare Genetic Disorders? A Narrative Review of the Literature
Capuano, I., Buonanno, P., Riccio, E., Crocetto, F., & Pisani, A. (2022) · Journal of Nephrology · doi:10.1007/s40620-022-01375-0 · Cited by 16
Tuberous Sclerosis (tsc2+/-) Model Eker Rats Reveals Extensive Neuronal Loss with Microglial Invasion and Vascular Remodeling Related to Brain Neoplasia
Kútna, V., Uttl, L., Waltereit, R., Krištofiková, Z., Kaping, D., Petrásek, T., Höschl, C., & Ovsepian, S. V. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00812-6 · Cited by 16
Experimental Approaches in Delineating mTOR Signaling
Qian, J., Su, S., & Liu, P. (2020) · Genes · doi:10.3390/genes11070738 · Cited by 17
Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse model
Kramer, K., Yang, J., Swanson, W. B., Hayano, S., Toda, M., Pan, H., Kim, J. K., Krebsbach, P. H., & Mishina, Y. M. (2018) · genesis · doi:10.1002/dvg.23220 · Cited by 17
Current Status of Mammalian Target of Rapamycin Inhibitors in Lung Cancer
Gómez-Martín, C., Rubio‐Viqueira, B., & Hidalgo, M. M. (2005) · Clinical Lung Cancer · doi:10.3816/clc.2005.s.003 · Cited by 16
Akt negatively regulates translation of the ternary complex factor Elk-1
Figueroa‐Romero, C., & Vojtek, A. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206496 · Cited by 16
Heterozygous inactivation of tsc2 enhances tumorigenesis in p53 mutant zebrafish
Kim, S., Kowalski, M. L., Carson, R. P., Bridges, L. R., & Ess, K. C. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.011494 · Cited by 16
TSC1 Controls Distribution of Actin Fibers through Its Effect on Function of Rho Family of Small GTPases and Regulates Cell Migration and Polarity
Ohsawa, M., Kobayashi, T., Okura, H., Igarashi, T., Mizuguchi, M., & Hino, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054503 · Cited by 15
Real-Time Monitoring of Tumorigenesis, Dissemination, & Drug Response in a Preclinical Model of Lymphangioleiomyomatosis/Tuberous Sclerosis Complex
Liu, F., Lunsford, E. P., Tong, J., Ashitate, Y., Gibbs, S. L., Yu, J. J., Choi, H. S., Henske, E. P., & Frangioni, J. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038589 · Cited by 15
Proteomic and Phosphoproteomic Analysis of Chicken Embryo Fibroblasts Infected with Cell Culture-Attenuated and Vaccine Strains of Marek’s Disease Virus
Chien, K.-Y., Blackburn, K., Liu, H., & Goshe, M. B. (2012) · Journal of Proteome Research · doi:10.1021/pr300471y · Cited by 15
Hemimegalencephaly and tuberous sclerosis complex: A rare yet challenging association
Sidira, C., Vargiami, E., Dragoumi, P., & Zafeiriou, D. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2020.12.007 · Cited by 16
TSC2 Mutations Were Associated with the Early Recurrence of Patients with HCC Underwent Hepatectomy
Song, K., He, F., Xin, Y., Guan, G., Huo, J., Zhu, Q., Fan, N., Guo, Y., Zang, Y.-J., & Wu, L.-Q. (2021) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s294307 · Cited by 15
Oncogenic role of MiR-130a in oral squamous cell carcinoma
Mallela, K., Swamy, S. S., Gopinath, K. S., & Kumar, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-87388-4 · Cited by 15
Modulo is a target of Myc selectively required for growth of proliferative cells in Drosophila
Perrin, L., Benassayag, C., Morello, D., Pradel, J., & Montagne, J. (2003) · Mechanisms of Development · doi:10.1016/s0925-4773(03)00049-2 · Cited by 15
Targeting NRF2 and FSP1 to Overcome Ferroptosis Resistance in TSC2-Deficient and Cancer Cells
Tahsin, T., McPhail, D. K., Champion, J. D., Alzahrani, M. A. M., Hilditch, M. L., Faris-Orr, A., Calver, B. L., Sexton, D. W., Cronin, J., Rivas, J. C. M., et al. (2025) · Cancers · doi:10.3390/cancers17162714 · Cited by 19
Self-citation
Change and Regulation of Nutritional Metabolism in Silver Pomfret During Compensatory Growth
Hu, J., Zhang, Y., Yan, K., Zhang, M., Li, Y., Li, Y., Gu, W., Xu, S., Wang, Y., & Yan, X. (2023) · Marine Biotechnology · doi:10.1007/s10126-023-10261-0 · Cited by 14
Synaptic Plasticity as a Therapeutic Target in the Treatment of Autism-related Single-gene Disorders
Pignatelli, M., Feligioni, M., Piccinin, S., Molinaro, G., Nicoletti, F., & Nisticò, R. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319360008 · Cited by 14
Phospho‐inositide‐dependent kinase 1 regulates signal dependent translation in megakaryocytes and platelets
Manne, B. K., Bhatlekar, S., Middleton, E. A., Weyrich, A. S., Borst, O., & Rondina, M. T. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14748 · Cited by 14
Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma
Wang, X., Xing, Z., Xu, H., Yang, H., & Xing, T. (2021) · Aging · doi:10.18632/aging.202976 · Cited by 14
Predisposition to tetraploidy in pulmonary vascular smooth muscle cells derived from the Eker rats
Gui, Y., He, G. H., Walsh, M. P., & Zheng, X. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00016.2007 · Cited by 14
Modulating Autophagy in Osteoarthritis: Exploring Emerging Therapeutic Drug Targets
Andrei, C., Mihai, D. P., Nițulescu, G. M., Nițulescu, G., & Zanfirescu, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413695 · Cited by 15
Sustained B7/CD28 interactions and resultant phosphatidylinositol 3‐kinase activity maintain G1→S phase transitions at an optimal rate
Bonnevier, J. L., Yarke, C. A., & Mueller, D. L. (2006) · European Journal of Immunology · doi:10.1002/eji.200535626 · Cited by 13
Tuberous sclerosis complex
O'Callaghan, F. J. (2008) · Paediatrics and Child Health · doi:10.1016/j.paed.2007.10.013 · Cited by 13
Role of mTOR Signaling for Tubular Function and Disease
Grahammer, F., Huber, T. B., & Artunç, F. (2021) · Physiology · doi:10.1152/physiol.00021.2021 · Cited by 13
Mechanical Disturbance of Osteoclasts Induces ATP Release That Leads to Protein Synthesis in Skeletal Muscle through an Akt-mTOR Signaling Pathway
Morales, C., Balanta‐Melo, J., Arias‐Calderón, M., Hernández, N., Gómez‐Valenzuela, F., Escobar, A. F., Jaimovich, E., & Buvinic, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169444 · Cited by 13
Everolimus improves behavioral deficits in a patient with autism associated with tuberous sclerosis: a case report
Ishii, R., Wataya‐Kaneda, M., Canuet, L., Nonomura, N., Nakai, Y., & Takeda, M. (2015) · Neuropsychiatric Electrophysiology · doi:10.1186/s40810-015-0004-x · Cited by 13
Genetic Syndromes Affecting Kidney Development
Pal, A., & Reidy, K. J. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-51436-9_10 · Cited by 13
The Mechanisms of Insulin Action
White, M. F., & Copps, K. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00033-0 · Cited by 12
Small molecule Y-320 stimulates ribosome biogenesis, protein synthesis, and aminoglycoside-induced premature termination codon readthrough
Hosseini-Farahabadi, S., Baradaran‐Heravi, A., Zimmerman, C., Choi, K., Flibotte, S., & Roberge, M. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001221 · Cited by 13
Indinavir alters regulators of protein anabolism and catabolism in skeletal muscle
Hong‐Brown, L. Q., Pruznak, A. M., Frost, R. A., Vary, T. C., & Lang, C. H. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00591.2004 · Cited by 13
Signal integration in the (m)TORC1 growth pathway
Ramlaul, K., & Aylett, C. H. S. (2018) · Frontiers in Biology · doi:10.1007/s11515-018-1501-7 · Cited by 12
An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma
Darawshi, O., Muz, B., Gershon-Naamat, S., Praveen, B., Mahameed, M., Goldberg, K., Dipta, P., Shmuel, M., Forno, F., Boukeileh, S., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05421-4 · Cited by 12
Signaling Pathways Leading to mTOR Activation Downstream Cytokine Receptors in Lymphocytes in Health and Disease
Fallone, L., Walzer, T., & Marçais, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612736 · Cited by 13
An updated meta-analysis of effectiveness and safety of mTOR inhibitors in the management of tuberous sclerosis complex patients
Liu, M., Ye, J., & You, X. (2023) · Child s Nervous System · doi:10.1007/s00381-023-06200-y · Cited by 12
Unraveling the function of TSC1-TSC2 complex: implications for stem cell fate
Wang, S., Ma, R., Gao, C., Tian, Y.-N., Hu, R., Zhang, H., Li, L., & Li, Y. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04170-3 · Cited by 15
Congenital lymphedema as a rare and first symptom of tuberous sclerosis complex
Klinner, J., Krüger, M., Brunet, T., Makowski, C. C., Riedhammer, K. M., Mollweide, A., Wagner, M., & Hoefele, J. (2020) · Gene · doi:10.1016/j.gene.2020.144815 · Cited by 12
Phakomatoses
Becker, B., & Strowd, R. E., III (2019) · Dermatologic Clinics · doi:10.1016/j.det.2019.05.015 · Cited by 12
Revisiting Brain Tuberous Sclerosis Complex in Rat and Human: Shared Molecular and Cellular Pathology Leads to Distinct Neurophysiological and Behavioral Phenotypes
Kútna, V., O’Leary, V. B., Newman, E. L., Höschl, C., & Ovsepian, S. V. (2021) · Neurotherapeutics · doi:10.1007/s13311-020-01000-7 · Cited by 13
Mechanisms of Insulin Action
White, M. F., & White, M. F. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1028-7_2 · Cited by 12
Retracted Tuberous sclerosis complex: molecular pathogenesis and animal models
Piedimonte, L. R., Wailes, I. K., & Weiner, H. L. (2006) · Neurosurgical FOCUS · doi:10.3171/foc.2006.20.1.5 · Cited by 12
Retracted
Small-molecule correctors divert CFTR-F508del from ERAD by stabilizing sequential folding states
Riepe, C., Wąchalska, M., Deol, K. K., Amaya, A. K., Porteus, M. H., Olzmann, J. A., & Kopito, R. R. (2023) · Molecular Biology of the Cell · doi:10.1091/mbc.e23-08-0336 · Cited by 12
Neuropsychological Problems in Neuro-oncology
Armstrong, C. L., Schmus, C. J., & Belasco, J. B. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1364-7_3 · Cited by 11
Risk factors for the development of autism spectrum disorder in children with tuberous sclerosis complex: protocol for a systematic review
Mitchell, R. A., Barton, S., Harvey, A. S., & Williams, K. J. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0448-0 · Cited by 11
Phosphoproteomics of cAMP signaling of Bordetella adenylate cyclase toxin in mouse dendritic cells
Novák, J., Fabrik, I., Linhartová, I., Link, M., Černý, O., Stulík, J., & Šebo, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-14501-x · Cited by 11
Construction of a robust prognostic model for adult adrenocortical carcinoma: Results from bioinformatics and real‐world data
Tian, X., Xu, W., Anwaier, A., Wang, H., Wan, F., Cao, D., Luo, W., Shi, G., Qu, Y., Zhang, H., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16323 · Cited by 11
Regulation of TORC1 by MAPK Signaling Determines Sensitivity and Acquired Resistance to Trametinib in Pediatric BRAFV600E Brain Tumor Models
Li, F., Bondra, K. M., Ghilu, S., Studebaker, A. W., Liu, Q., Michalek, J. E., Kogiso, M., Li, X., Kalapurakal, J. A., James, C. D., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1052 · Cited by 12
Diabetes Diminishes Phosphatidic Acid in the Retina: A Putative Mediator for Reduced mTOR Signaling and Increased Neuronal Cell Death
Fox, T. E., Young, M. M., Pedersen, M. M., Han, X., Gardner, T. W., & KESTER, M. A. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7626 · Cited by 11
Emerging treatments and personalised medicine for ciliopathies associated with cystic kidney disease
Molinari, E., & Sayer, J. A. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2017.1372282 · Cited by 11
Western Diet-Mediated mTORC1-Signaling in Acne, Psoriasis, Atopic Dermatitis, and Related Diseases of Civilization: Therapeutic Role of Plant-Derived Natural mTORC1 Inhibitors
Melnik, B. C. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-167-7_37 · Cited by 11
Determining the pathogenicity of patient-derived TSC2 mutations by functional characterization and clinical evidence
Dunlop, E. A., Dodd, K. M., Land, S. C., Davies, P. A., Martins, N., Stuart, H., McKee, S. A., Kingswood, J. C., Saggar, A., Corderio, I., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.38 · Cited by 11
Self-citation
Investigational agents for treatment of AIDS-related Kaposi’s sarcoma
Konstantinopoulos, P. A., Sullivan, R. J., Karamouzis, M. V., & Dezube, B. J. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.4.495 · Cited by 11
Ras mediates cell survival by regulating tuberin
Freilinger, A., Rosner, M. R., Hanneder, M., & Hengstschläger, M. (2008) · Oncogene · doi:10.1038/sj.onc.1210844 · Cited by 14
Regulation of PCNA and CAF-1 expression by the two tuberous sclerosis gene products
Hengstschläger, M., Rosner, M., Fountoulakis, M., & Lübec, G. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01238-5 · Cited by 11
Enhancing productivity of Chinese hamster ovary (CHO) cells: synergistic strategies combining low-temperature culture and mTORC1 signaling engineering
Shahabi, F., Abdoli, S., Bazi, Z., Shamsabadi, F. T., Yamchi, A., & Shahbazi, M. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1268048 · Cited by 10
Rapamycin improves the survival of epilepsy model cells by blocking phosphorylation of mTOR base on computer simulations and cellular experiments
Li, K., Cao, J., Gong, Y., Li, X., Wu, M., Qi, Y., Ying, X., Liu, D., Ma, X., & Zhang, X. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105746 · Cited by 10
Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor
Moavero, R., Folgiero, V., Carai, A., Miele, E., Ferretti, E., Pò, A., Diomedi‐Camassei, F., Lepri, F. R., Vigevano, F., Curatolo, P., et al. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25851 · Cited by 10
The Molecular Landscape Influencing Prognoses of Epithelial Ovarian Cancer
Liu, C.-L., Yuan, R., & Mao, T. (2021) · Biomolecules · doi:10.3390/biom11070998 · Cited by 10
Tuber Brain Proportion Determines Epilepsy Onset in Children With Tuberous Sclerosis Complex
Zhang, F., Xie, L., He, X., Song, X., Zheng, H., Wang, L., & Jiang, L. (2021) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2021.12.012 · Cited by 10
Rare and Unusual Endocrine Cancer Syndromes With Mutated Genes
Lodish, M. B., & Stratakis, C. A. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.10.019 · Cited by 10
Tsc2 Expression Increases the Susceptibility of Renal Tumor Cells to Apoptosis
Kolb, T. M., Duan, L., & Davis, M. A. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi310 · Cited by 10
Phosphoinositide signalling in type 2 diabetes: a β-cell perspective
Rameh, L. E., & Deeney, J. T. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150229 · Cited by 9
The characterization of RHEB gene and its responses to hypoxia and thermal stresses in the small abalone Haliotis diversicolor
He, L., Zhang, X., Huang, Y., Yang, H., Wang, Y., & Zhang, Z. (2017) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2017.06.001 · Cited by 9
Emerging Link between Tsc1 and FNIP Co-Chaperones of Hsp90 and Cancer
Backe, S. J., Sager, R., Meluni, K. A., Woodford, M. R., Bourboulia, D., & Mollapour, M. (2022) · Biomolecules · doi:10.3390/biom12070928 · Cited by 9
Nonsense mutation suppression is enhanced by targeting different stages of the protein synthesis process
Wittenstein, A., Caspi, M., Rippin, I., Elroy‐Stein, O., Eldar-Finkelman, H., Thoms, S., & Rosin‐Arbesfeld, R. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002355 · Cited by 11
Pulmonary Cystic Disease and Its Mimics
Jones, K. D. (2020) · Surgical pathology clinics · doi:10.1016/j.path.2019.11.007 · Cited by 9
Benign Brain Tumors and Tumors Associated With Phakomatoses
Daras, M., & Kaley, T. J. (2015) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000464177.73440.44 · Cited by 8
MR Imaging Detection of CNS Lesions in Tuberous Sclerosis Complex: The Usefulness of T1WI with Chemical Shift Selective Images
Fujii, H., Sato, N., Kimura, Y., Mizutani, M., Kusama, M., Sumitomo, N., Chiba, E., Shigemoto, Y., Takao, M., Takayama, Y., et al. (2022) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7573 · Cited by 8

Authors: Tee, A. R., Fingar, D. C., Manning, B. D., Kwiatkowski, D. J., Cantley, L. C., & Blenis, J.
Affiliations: Brigham and Women's Hospital (US)
Corresponding author: Blenis, John
ORCID: Tee, Andrew R.
Fingar, Diane C.
Manning, Brendan D.
Kwiatkowski, David J.
Cantley, Lewis C.
Blenis, John
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2002-09-23
Volume: 99
Issue: 21
Pages: 13571-13576
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.202476899
PMC: PMC129715
OpenAlex: W2087812126
Cited by: 827
References: 31
Citations by year: 2026: 9 · 2025: 13 · 2024: 17 · 2023: 27 · 2022: 29 · 2021: 35 · 2020: 40 · 2019: 22 · 2018: 37 · 2017: 35 · 2016: 31 · 2015: 45 · 2014: 28 · 2013: 43 · 2012: 42
FWCI: 17.27
Type: journal article
Language: en
Update notices: correction (2021-08-09)
Open access: green
europepmc.org
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of General Medical Sciences (GM 41890, GM51405, R01GM056203, GM 56203, R01GM051405, R01GM041890, R37GM041890)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: tuberous sclerosis complex, TSC1, TSC2, hamartin, tuberin, mTOR signaling, 4E-BP1, S6K1, amino acid signaling, nutrient deprivation, rapamycin resistance, protein phosphorylation, eIF4E, tumor formation
MeSH terms: Tuberous Sclerosis Complex 1 Protein, Tuberous Sclerosis Complex 2 Protein, Amino Acids, Carrier Proteins, Cell Line, Humans, Insulin, Models, Biological, Phosphoproteins, Phosphorylation, Protein Kinases, Proteins, Repressor Proteins, Tuberous Sclerosis, Signal Transduction, Point Mutation, Cell Cycle Proteins, Phosphatidylinositol 3-Kinases, Ribosomal Protein S6 Kinases, Tumor Suppressor Proteins, Adaptor Proteins, Signal Transducing, TOR Serine-Threonine Kinases, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks